Business Wire

Jupiter Endovascular Announces First Patients Successfully Treated in First Clinical Study of Vertex Pulmonary Embolectomy System Using Endoportal Control

MENLO PARK, Calif.--(BUSINESS WIRE)--Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™, announced today that the ...
Yahoo

Jupiter Endovascular’s pulmonary embolectomy system hits primary endpoints in trial

Jupiter Endovascular has shared positive pivotal trial results for its Vertex pulmonary embolectomy system in treating pulmonary embolism (PE). The 123-patient SPIRARE II trial (NCT06576427) evaluated ...
Business Wire

Jupiter Endovascular Announces First U.S. Patient Treated With Vertex Pulmonary Embolectomy System Using Endoportal Control

MENLO PARK, Calif.--(BUSINESS WIRE)--Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™, announced today that the ...
Healio

FDA approves study assessing pulmonary embolectomy system with Endoportal Control

Please provide your email address to receive an email when new articles are posted on . “SPIRARE opens the door for a new generation of large-bore interventional technology, designed for increased ...
Staten Island Advance

Groundbreaking pulmonary embolism procedure performed at Staten Island University Hospital

STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital (SIUH) in Ocean Breeze has become the first medical facility in the United States to treat acute pulmonary embolism (PE) using the ...
Morningstar

Jupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial at EuroPCR 2026

Vertex Pulmonary Embolectomy System demonstrated significant right heart recovery, low adverse event rates, and reproducible performance across high-severity PE patients Jupiter Endovascular, Inc.
MD&M East

Jupiter Endovascular Surpasses Funding Goal, Hits FDA Milestone

Medical technology startup Jupiter Endovascular has closed on a round of Series B funding, surpassing its $40 million goal. The funding was led by investor group Sonder Capital, which has also ...
Yahoo Finance

Jupiter Endovascular Announces Completion of Enrollment in SPIRARE II Pivotal Trial

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
FierceBiotech

Jupiter Endovascular's Vertex TFX catheter platform study shows positive results

Jupiter Endovascular, which was formed by Neptune Medical a little more than a year ago, shared positive results from the first-in-human trial of its Vertex TFX catheter platform. As part of its ...
Endovascular Today

Jupiter Endovascular Appoints Dr. Catalin Toma as Chief Medical Officer

Jupiter Endovascular Inc., announced the appointment of interventional cardiologist Catalin Toma, MD, as Chief Medical ...
TMCnet

Jupiter Endovascular Appoints Catalin Toma, MD, as Chief Medical Officer

Jupiter Endovascular Inc., a medical technology company developing a new class of endovascular interventions based on its proprietary Transforming Fixation (TFX) technology, today announced the ...